Cas no 1100095-09-7 ([3-(pyrrolidin-1-ylmethyl)phenyl]boronic acid)
[3-(pyrrolidin-1-ylmethyl)phenyl]boronic acid Chemical and Physical Properties
Names and Identifiers
-
- (3-(Pyrrolidin-1-ylmethyl)phenyl)boronic acid
- [3-(pyrrolidin-1-ylmethyl)phenyl]boronic acid
- 3-(Pyrrolidin-1-ylmethyl)phenylboronic acid
-
- MDL: MFCD08060616
- Inchi: 1S/C11H16BNO2/c14-12(15)11-5-3-4-10(8-11)9-13-6-1-2-7-13/h3-5,8,14-15H,1-2,6-7,9H2
- InChI Key: JRGCMBMTOLSYTF-UHFFFAOYSA-N
- SMILES: OB(C1=CC=CC(=C1)CN1CCCC1)O
Computed Properties
- Hydrogen Bond Donor Count: 2
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 15
- Rotatable Bond Count: 3
[3-(pyrrolidin-1-ylmethyl)phenyl]boronic acid Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Matrix Scientific | 148084-1g |
(3-(Pyrrolidin-1-ylmethyl)phenyl)boronic acid, 95% |
1100095-09-7 | 95% | 1g |
$602.00 | 2023-09-10 | |
| TRC | P122180-100mg |
(3-(Pyrrolidin-1-ylmethyl)phenyl)boronic acid |
1100095-09-7 | 100mg |
$ 275.00 | 2022-06-03 | ||
| TRC | P122180-250mg |
(3-(Pyrrolidin-1-ylmethyl)phenyl)boronic acid |
1100095-09-7 | 250mg |
$ 565.00 | 2022-06-03 | ||
| TRC | P122180-500mg |
(3-(Pyrrolidin-1-ylmethyl)phenyl)boronic acid |
1100095-09-7 | 500mg |
$ 900.00 | 2022-06-03 | ||
| Alichem | A109007209-1g |
(3-(Pyrrolidin-1-ylmethyl)phenyl)boronic acid |
1100095-09-7 | 95% | 1g |
$443.10 | 2023-09-04 | |
| Chemenu | CM136264-5g |
(3-(Pyrrolidin-1-ylmethyl)phenyl)boronic acid |
1100095-09-7 | 95% | 5g |
$972 | 2023-11-25 | |
| eNovation Chemicals LLC | D323254-1g |
3-(1-Pyrrolidinylmethyl)phenylboronic acid |
1100095-09-7 | 97% | 1g |
$494 | 2024-05-24 | |
| SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd. | P856146-1g |
(3-(Pyrrolidin-1-ylmethyl)phenyl)boronic acid |
1100095-09-7 | 98% | 1g |
¥3,627.00 | 2022-09-01 | |
| Enamine | EN300-241917-0.05g |
{3-[(pyrrolidin-1-yl)methyl]phenyl}boronic acid |
1100095-09-7 | 95% | 0.05g |
$94.0 | 2024-06-19 | |
| Enamine | EN300-241917-0.1g |
{3-[(pyrrolidin-1-yl)methyl]phenyl}boronic acid |
1100095-09-7 | 95% | 0.1g |
$140.0 | 2024-06-19 |
[3-(pyrrolidin-1-ylmethyl)phenyl]boronic acid Related Literature
-
Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550
-
Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
-
P. K. Wawrzyniak,M. T. P. Beerepoot,H. J. M. de Groot,F. Buda Phys. Chem. Chem. Phys., 2011,13, 10270-10279
-
Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
Additional information on [3-(pyrrolidin-1-ylmethyl)phenyl]boronic acid
Introduction to [3-(pyrrolidin-1-ylmethyl)phenyl]boronic acid (CAS No. 1100095-09-7)
[3-(Pyrrolidin-1-ylmethyl)phenyl]boronic acid (CAS No. 1100095-09-7) is a versatile organic compound that has garnered significant attention in the fields of organic synthesis, medicinal chemistry, and materials science. This compound is characterized by its unique structure, which combines a boronic acid moiety with a pyrrolidine-substituted benzene ring. The combination of these functional groups endows the molecule with a range of chemical properties that make it valuable for various applications.
The boronic acid group in [3-(pyrrolidin-1-ylmethyl)phenyl]boronic acid is particularly noteworthy due to its reactivity and ability to form stable complexes with a variety of organic and inorganic compounds. This property has been extensively exploited in Suzuki-Miyaura coupling reactions, which are widely used in the synthesis of biologically active molecules, including pharmaceuticals and agrochemicals. The pyrrolidine substituent, on the other hand, imparts additional functionality and can influence the overall reactivity and selectivity of the molecule.
Recent research has highlighted the potential of [3-(pyrrolidin-1-ylmethyl)phenyl]boronic acid in the development of new therapeutic agents. For instance, a study published in the Journal of Medicinal Chemistry demonstrated that this compound can serve as a key intermediate in the synthesis of potent inhibitors of protein-protein interactions (PPIs). PPI inhibitors are a promising class of drugs that target disease-causing interactions between proteins, making them valuable for treating conditions such as cancer and neurodegenerative disorders.
In addition to its applications in medicinal chemistry, [3-(pyrrolidin-1-ylmethyl)phenyl]boronic acid has also shown promise in materials science. The boronic acid group can form covalent bonds with hydroxyl groups on surfaces, making it useful for surface modification and functionalization. This property has been utilized to create functional coatings and materials with enhanced properties, such as improved adhesion, reduced friction, and increased biocompatibility.
The synthesis of [3-(pyrrolidin-1-ylmethyl)phenyl]boronic acid typically involves several steps, including the formation of the pyrrolidine-substituted benzene ring and subsequent introduction of the boronic acid group. Various synthetic routes have been reported in the literature, each with its own advantages and limitations. One common approach involves the use of palladium-catalyzed cross-coupling reactions to introduce the boronic acid functionality onto the aromatic ring.
The physical and chemical properties of [3-(pyrrolidin-1-ylmethyl)phenyl]boronic acid have been well-characterized. It is a white crystalline solid that is soluble in polar solvents such as water and methanol. The compound exhibits good thermal stability and can be stored under standard laboratory conditions without significant degradation. These properties make it suitable for use in both academic research and industrial applications.
In conclusion, [3-(pyrrolidin-1-ylmethyl)phenyl]boronic acid (CAS No. 1100095-09-7) is a multifunctional compound with a wide range of applications in organic synthesis, medicinal chemistry, and materials science. Its unique combination of functional groups provides it with valuable chemical properties that have been leveraged in various research and development efforts. As ongoing studies continue to uncover new uses for this compound, it is likely to remain an important tool in the chemist's arsenal for years to come.
1100095-09-7 ([3-(pyrrolidin-1-ylmethyl)phenyl]boronic acid) Related Products
- 944483-39-0([3-(diethylaminomethyl)phenyl]boronic acid)
- 1032610-59-5([3-(1-piperidylmethyl)phenyl]boronic acid)
- 397843-59-3(Boronic acid, [3-[[methyl(phenylmethyl)amino]methyl]phenyl]-)
- 1036991-20-4({4-[(pyrrolidin-1-yl)methyl]phenyl}boronic acid)
- 1200434-84-9(4-(1-Piperidylmethyl)phenylboronic Acid)
- 1301198-10-6(Boronic acid, 4-(1-piperidinylmethyl)phenyl-, hydrochloride)
- 397843-57-1(Boronic acid, [3-[[(2-methylpropyl)amino]methyl]phenyl]-)
- 868395-81-7(4-(1-Pyrrolidinoethyl)phenylboronic Acid)
- 1256355-44-8(3-(1-Pyrrolidinoethyl)phenylboronic Acid)
- 1072946-21-4((3-(Piperidin-1-ylmethyl)phenyl)boronic acid hydrochloride)